Evaluation of the use of Telemedicine in Pediatric Intensive Care Units: Randomized Controlled Trial.

Not Applicable

• Conditions: nspecified bacterial pneumonia; Acute respiratory failure; Hydrocephalus; Spinal muscular atrophy, type I (Werdnig-Hoffman); A41.9

• Registration Number: RBR-7xj4wyp
• Lead Sponsor: Programa de Apoio ao Desenvolvimento Institucional do Sistema Único de Saúde

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-22
• Last Update Posted: 29 May 2023
• Study Completion: 2023-12-01

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

All children admitted in the pediatric Intensive Care Unit (ICU) aged bigger or equal 29 days and smaller 18 years, with a length of stay greater than 8 hours, and in case of death, greater than 24 hours

Exclusion Criteria

Patients with incomplete medical records or with incomplete data in the institution's database; patients whose guardians did not accept to participate in the study and/or who did not sign the Informed Consent Form (FICF) and term of use of image

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Our primary outcome will be the length of stay, which will be presented in days and calculated by subtracting the date of discharge from the date of admission to the Pediatric Intensive Care Unit

Secondary Outcome Measures

Name	Time	Method
As secondary outcomes, we will evaluate the mortality rate, which will be estimated by dividing the number of deaths in each unit by the number of patients discharged during the telemedicine follow-up period. In addition, we will evaluate days free from mechanical ventilation, as well as the time of use of vasoactive drugs, time of use of broad-spectrum antibiotic and time of use of sedation and analgesia<br>